BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38538318)

  • 1. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
    Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
    J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y; Zhou J; Wang L; Li JY; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.
    Dong P; Wang L; Shen G; Li L
    Medicine (Baltimore); 2019 Mar; 98(11):e14818. PubMed ID: 30882662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
    Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
    Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pretreatment evaluation of
    Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
    Huang M; Wang R; Shen G; Tian R
    Clin Nucl Med; 2022 Oct; 47(10):914-915. PubMed ID: 35619195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.
    Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY
    Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09).
    Lee TH; Kim HJ; Lee JH; Lee J; Kim JH; Oh D; Eom KY
    Cancer Res Treat; 2024 Apr; 56(2):688-696. PubMed ID: 38097921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
    Li FL; Su MG; Shi DZ; Liang FL; Li L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.
    Wang Y; Xie L; Tian R; Deng Y; Zhang W; Zou L; Zhang H; Liu J; Zhao S; Ding W; Liu W; Jiang M
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2529-2539. PubMed ID: 31485768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
    Berk V; Yildiz R; Akdemir UO; Akyurek N; Karabacak NI; Coskun U; Benekli M
    Clin Nucl Med; 2008 May; 33(5):365-6. PubMed ID: 18431160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
    Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
    Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
    Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
    Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.